DARPin-fused T cell engager for adenovirus-mediated cancer therapy.

Freitag PC, Kolibius J, Wieboldt R, Weber R, Hartmann KP, van Gogh M, Brücher D, Läubli H, Plückthun A

Open source

DOI
10.1016/j.omton.2024.200821
Published
2024 Sep 19
Container
Molecular therapy. Oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.omton.2024.200821,
  title = {DARPin-fused T cell engager for adenovirus-mediated cancer therapy.},
  author = {Freitag PC and Kolibius J and Wieboldt R and Weber R and Hartmann KP and van Gogh M and Brücher D and Läubli H and Plückthun A},
  year = {2024},
  journal = {Molecular therapy. Oncology},
  doi = {10.1016/j.omton.2024.200821},
  url = {https://doi.org/10.1016/j.omton.2024.200821}
}

RIS

TY  - JOUR
TI  - DARPin-fused T cell engager for adenovirus-mediated cancer therapy.
AU  - Freitag PC
AU  - Kolibius J
AU  - Wieboldt R
AU  - Weber R
AU  - Hartmann KP
AU  - van Gogh M
AU  - Brücher D
AU  - Läubli H
AU  - Plückthun A
PY  - 2024
JO  - Molecular therapy. Oncology
DO  - 10.1016/j.omton.2024.200821
UR  - https://doi.org/10.1016/j.omton.2024.200821
ER  - 

APA

PC, F., J, K., R, W., R, W., KP, H., M, V. G., D, B., H, L., & A, P. (2024). DARPin-fused T cell engager for adenovirus-mediated cancer therapy.. Molecular therapy. Oncology. https://doi.org/10.1016/j.omton.2024.200821

Source records